alexa Chemotherapy In Breast Cancer Patients With Pregnancy And Its Effects On Fetal Outcome: A Review | 23051
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials

Paturi Rohith
Posters: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.014
Abstract
Due to a circumscribed number of studies on fetal and maternal effects following the utilization of chemotherapy in breast cancer patients with pregnancy, this review is aimed at identifying the safety of chemotherapy, along with identification of safe chemotherapeutic drugs in such patients. Data required for thereview were obtained from various articles acquired by conducting an ample search through Medline/PubMed, Google Scholar, Cochrane databases using different keywords. The articles thus obtained were further filtered by 3 readers on basis of required parameters for the study. The list of drugs in various regimens used in this review included doxorubicin, epirubicin, docetaxel, paclitaxel, 5 -fluorouracil, cyclophosphamide, trastuzumab, vinorelbine andlapatinib. Different studies have shown the highest rate of fetal malformations in patients who were started on chemotherapy in the first trimester. Perinatal mortality was high with use of doxorubicin and other anthracycline based chemotherapy regimens when used in first trimester when compared to second and third trimesters. Many studies have shown that the use of doxorubicin, epirubicin, docetaxel and paclitaxel in second and third trimesters have least unpleasant effects on the fetus. Oligohydranimos and anhydranimos were observed in the patients who received trastuzumab. Despite of few cases of vinorelbine use in pregnant patients for breast cancer, neither fetal abnormalities nor maternal complications were identified. No fetal abnormalities were observed in the patient who received lapatinib. This review concludes that breast cancer can be treated with chemotherapy during second and third trimesters of pregnancy with minimal fetal and maternal complications.
Biography
Paturi Rohith is pursuing his internship in Doctor of Pharmacy at JSS College of Pharmacy, Mysore, JSS University. He has done his thesis entitled ?Initiation and Evaluation of Patient Reporting ADR?s in Outpatient Department of JSS Hospital (which is tertiary care teaching hospital)?. He attended various international and national conferences and workshops like WCCPCI, IACP Inaugural convention-2014.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version